
COVID-19 Vaccines Market by Product Type (Monovalent Vaccine, Multivalent Vaccine), End-User (Academic & Research Centers, Clinics, Hospitals), Patient Type - Global Forecast 2024-2030
Description
COVID-19 Vaccines Market by Product Type (Monovalent Vaccine, Multivalent Vaccine), End-User (Academic & Research Centers, Clinics, Hospitals), Patient Type - Global Forecast 2024-2030
The COVID-19 Vaccines Market size was estimated at USD 215.43 billion in 2023 and expected to reach USD 237.12 billion in 2024, at a CAGR 10.55% to reach USD 434.83 billion by 2030.
Global COVID-19 Vaccines Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the COVID-19 Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the COVID-19 Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the COVID-19 Vaccines Market, highlighting leading vendors and their innovative profiles. These include AIVITA Biomedical Inc., AstraZeneca PLC, Baseimmune Ltd., Bharat Biotech International Ltd., Biological E. Ltd., CanSino Biologics Inc., Centivax Inc., Codagenix Inc., CureVac SE, Dr. Reddy's Laboratories Ltd., Emergex Vaccines Holding Ltd., Etherna Immunotherapies NV, Gennova Biopharmaceuticals Ltd., GlaxoSmithKline PLC, HDT Bio, Inc., Meissa Vaccines, Inc., Merck & Co., Inc., Moderna, Inc., Novavax Inc., Osivax SAS, Pfizer Inc., Providence Therapeutics Inc., SANOFI, Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Vaccitech PLC, and Zydus Lifesciences Ltd..
Market Segmentation & Coverage
This research report categorizes the COVID-19 Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product Type
Monovalent Vaccine
Multivalent Vaccine
End-User
Academic & Research Centers
Clinics
Hospitals
Vaccination Centers
Patient Type
Adult
Pediatric
Senior Citizens
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the COVID-19 Vaccines Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the COVID-19 Vaccines Market?
3. What are the technology trends and regulatory frameworks in the COVID-19 Vaccines Market?
4. What is the market share of the leading vendors in the COVID-19 Vaccines Market?
5. Which modes and strategic moves are suitable for entering the COVID-19 Vaccines Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
195 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. COVID-19 Vaccines Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rapid spread of coronavirus resulting in a large number of deaths
- 5.1.1.2. Government support and grants for COVID-19 vaccines
- 5.1.1.3. Increasing research and development (R&D) initiatives for vaccines
- 5.1.2. Restraints
- 5.1.2.1. Limited supportive infrastructure, skills, and technology in developing areas around the world
- 5.1.3. Opportunities
- 5.1.3.1. Growing amalgamation activities to manufacture and distribute the COVID-19 vaccines
- 5.1.3.2. Rising investments for vaccines
- 5.1.4. Challenges
- 5.1.4.1. Side effects associated with the COVID-19 vaccines
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. COVID-19 Vaccines Market, by Product Type
- 6.1. Introduction
- 6.2. Monovalent Vaccine
- 6.3. Multivalent Vaccine
- 7. COVID-19 Vaccines Market, by End-User
- 7.1. Introduction
- 7.2. Academic & Research Centers
- 7.3. Clinics
- 7.4. Hospitals
- 7.5. Vaccination Centers
- 8. COVID-19 Vaccines Market, by Patient Type
- 8.1. Introduction
- 8.2. Adult
- 8.3. Pediatric
- 8.4. Senior Citizens
- 9. Americas COVID-19 Vaccines Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific COVID-19 Vaccines Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa COVID-19 Vaccines Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. AIVITA Biomedical Inc.
- 13.1.2. AstraZeneca PLC
- 13.1.3. Baseimmune Ltd.
- 13.1.4. Bharat Biotech International Ltd.
- 13.1.5. Biological E. Ltd.
- 13.1.6. CanSino Biologics Inc.
- 13.1.7. Centivax Inc.
- 13.1.8. Codagenix Inc.
- 13.1.9. CureVac SE
- 13.1.10. Dr. Reddy's Laboratories Ltd.
- 13.1.11. Emergex Vaccines Holding Ltd.
- 13.1.12. Etherna Immunotherapies NV
- 13.1.13. Gennova Biopharmaceuticals Ltd.
- 13.1.14. GlaxoSmithKline PLC
- 13.1.15. HDT Bio, Inc.
- 13.1.16. Meissa Vaccines, Inc.
- 13.1.17. Merck & Co., Inc.
- 13.1.18. Moderna, Inc.
- 13.1.19. Novavax Inc.
- 13.1.20. Osivax SAS
- 13.1.21. Pfizer Inc.
- 13.1.22. Providence Therapeutics Inc.
- 13.1.23. SANOFI
- 13.1.24. Serum Institute of India Pvt. Ltd.
- 13.1.25. Sinovac Biotech Ltd.
- 13.1.26. Vaccitech PLC
- 13.1.27. Zydus Lifesciences Ltd.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. COVID-19 VACCINES MARKET RESEARCH PROCESS
- FIGURE 2. COVID-19 VACCINES MARKET SIZE, 2023 VS 2030
- FIGURE 3. COVID-19 VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. COVID-19 VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. COVID-19 VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. COVID-19 VACCINES MARKET DYNAMICS
- FIGURE 7. COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
- FIGURE 8. COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. COVID-19 VACCINES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 10. COVID-19 VACCINES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
- FIGURE 12. COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. COVID-19 VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. COVID-19 VACCINES MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.